Immunome

Manufacturing · Washington, United States · 201-500 Employees

View Company Info for Free

Overview

Headquarters

18702 North Creek Pkwy Ste 100, Bothell,...

Phone Number

(425) 939-7410

Revenue

-

Stock Symbol

IMNM

Industry

Manufacturing Pharmaceuticals Business Services Research & Development

About Immunome

Immunome is a biopharmaceutical company that utilizes its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics that are designed to change the way diseases are treated. The company's initial focus is developing therapeutics to treat oncology and infectious diseases, including COVID-19. Immunome's proprietary discovery engine identifies novel therapeutic antibodies and their targets by leveraging the highly educated components of the immune system, memory B cells, from patients whose bodies have learned to fight off their disease.Explore more
Immunome's Social MediaSIC Code 28,283NAICS Code 32,325Ticker NASDAQ: IMNMShow more

Immunome Org Chart

Clay Siegall, President & Chief Executive Officer at Immunome
United States flag for contact location.

President & Chief Executive Officer

PhoneEmail
Sandra Stoneman, Chief Legal Officer & General Counsel at Immunome
United States flag for contact location.

Chief Legal Officer & General Counsel

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
CS
United States flag for contact location.

Vice President, Regulatory Affairs, Al102

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Immunome

Compare insights from companies similar to Immunome, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Immunome

201-500
Public
$201.4M
2006
Clay Siegall, President & Chief Executive Officer at Immunome
Clay SiegallPresident & CEO
$232.4M
51-200
Public
$265.9M
2005
Eric Loumeau, Chief Legal Officer at AnaptysBio
Eric LoumeauChief Legal Officer
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
$89.5M
51-200
Public
$177.8M
2016
Jingsong Wang, Founder & Chief Executive Officer at Harbour BioMed
Jingsong WangFounder & CEO
$85.7M
51-200
Public
$129.4M
1998
Helen Sabzevari, President & Chief Executive Officer at Precigen
Helen SabzevariPresident & CEO
$28.7M
51-200
Private
$106M
2018
YX
Yue XiongChief Scientific Officer
<$5M
51-200
Private
-
2018
WM
Weiwei MaoVice President & Head of Quality
Illustration of an envelope

Immunome Tech Stack

A closer look at the technologies used by Immunome

Top Manufacturing Companies

Frequently Asked Questions Regarding Immunome

What is Immunome's stock symbol?
Immunome's stock symbol is IMNM
What is Immunome's official website?
Immunome's official website is www.immunome.com
What is Immunome's SIC code?
Immunome's SIC: 28,283
What is Immunome's NAICS code?
Immunome's NAICS: 32,325
How many employees does Immunome have?
Immunome has 201-500 employees
What industry does Immunome belong to?
Immunome is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Immunome competition?
Immunome top competitors include: Agenus, AnaptysBio, Harbour BioMed, Precigen
What companies has Immunome acquired?
Immunome has acquired the companies: Morphimmune
What technology does Immunome use?
Some of the popular technologies that Immunome uses are: WordPress.org, PHP, Google Universal Analytics, ServiceNow
How do I contact Immunome?
Immunome contact info: Phone number: (425) 939-7410 Website: www.immunome.com
What does Immunome do?

Immunome is a biopharmaceutical company that utilizes its proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics that are designed to change the way diseases are treated. The company's initial focus is developing therapeutics to treat oncology and infectious diseases, including COVID-19. Immunome's pro... prietary discovery engine identifies novel therapeutic antibodies and their targets by leveraging the highly educated components of the immune system, memory B cells, from patients whose bodies have learned to fight off their disease.Read More

What are Immunome social media links?
Immunome Linkedin page Immunome Twitter page
Is Immunome a public company?
Yes, Immunome is a public company and is traded under the symbol IMNM
See more information about Immunome

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.